What is dual-antiplatelet therapy and why is it important during PCI?
Dual-antiplatelet therapy is an essential part of preventing stent thrombosis in patients treated with stents during percutaneous coronary intervention (PCI). It involves the use of two different antiplatelet agents, such as aspirin and clopidogrel, to reduce the risk of blood clot formation and subsequent stent thrombosis. This combination of medications is also used to reduce the risk of stroke and heart attack in patients with coronary artery disease. 